CG ONCOLOGY INC (CGON:NASDAQ)
$59.85 -2.01 (-3.2493%)
Analysed CG ONCOLOGY INC (CGON:NASDAQ) News Sources
Did CG Oncology’s Leadership Consolidation Around CEO Kuan Just Shift CGON’s Commercialization Narrative?
31-05-2026
yahoo.com
CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push
07-06-2026
marketbeat.com
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead
10-06-2026
marketbeat.com
CG Oncology Stock Gains 12% in Three Months: What's Driving It?
13-07-2026
yahoo.com
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
27-07-2026
yahoo.com
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
06-08-2026
yahoo.com
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
26-08-2026
yahoo.com
CG Oncology (CGON) Stock Looks Fully Priced After A 160% Run
03-09-2026
yahoo.com
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
13-10-2026
yahoo.com
How Investors May Respond To CG Oncology (CGON) Hiring a CCO Before Potential Bladder Cancer Launch
14-10-2026
yahoo.com
What is the current price of CG ONCOLOGY INC (CGON:NASDAQ)?
The current price of CG ONCOLOGY INC (CGON:NASDAQ) is $59.85.
CG ONCOLOGY INC (CGON:NASDAQ) absolute price change since previous trading day?
The absolute price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is $-2.01.
CG ONCOLOGY INC (CGON:NASDAQ) percentage price change since previous trading day?
The percentage price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is -3.2493%.
What is the most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent sentiment for CG ONCOLOGY INC (CGON:NASDAQ) is .
SEC-8K** Filing Available For CG ONCOLOGY INC (CGON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.